Browse by Title

Type here to filter the list

N
Naloxone Saturation: An Overview and Models for Success

Maya Doe-Simkins, MPH (she/her/hers) – Remedy Alliance ### 1827416###Presenter###Co-director###Remedy Alliance###
Presenter: Maya Doe-Simkins, MPH (she/her/hers) – Remedy Alliance
### she/her/hers @@@ Corey Davis, JD, MSPH – Network for Public Health Law ### 1827417###Presenter###Director, Harm Reduction Legal Project###Network for Public Health Law###
Presenter: Corey Davis, JD, MSPH – Network for Public Health Law
### @@@ Barbara J. Bazron, PhD – DC Department of Behavioral Health ### 1930620###Presenter###Director###DC Department of Behavioral Health###
Presenter: Barbara J. Bazron, PhD – DC Department of Behavioral Health
### @@@ Sari Frankel, MPH (she/her/hers) – DC Department of Behavioral Health ### 1827407###Presenter###Harm Reduction Supervisor###DC Department of Behavioral Health###
Presenter: Sari Frankel, MPH (she/her/hers) – DC Department of Behavioral Health
### she/her/hers @@@ Cecelia M. Spitznas, PhD – Office of National Drug Control Policy ### 670861###Moderator###Senior Science Policy Advisor###Office of National Drug Control Policy###
Moderator: Cecelia M. Spitznas, PhD – Office of National Drug Control Policy
###
National Emerging Threats: The Latest Data and Trends

John L. Eadie, MPA – National Emerging Threats Initiative ### 651996###Presenter###Public Health and PDMP Project Coordinator###National Emerging Threats Initiative###
Presenter: John L. Eadie, MPA – National Emerging Threats Initiative
### @@@ Jackie L. Steele, JD – Kentucky 27th Judicial Circuit ### 670870###Moderator###Commonwealth's Attorney###Kentucky 27th Judicial Circuit###
Moderator: Jackie L. Steele, JD – Kentucky 27th Judicial Circuit
###
Nonprescription Naloxone: Update and Implications

Marta Sokolowska, PhD – U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of the Center Director ### 1293677###Presenter###Deputy Center Director for Substance Use and Behavioral Health###U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of the Center Director###
Presenter: Marta Sokolowska, PhD – U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of the Center Director
### @@@ Jon Woodruff, JD (he/him/his) – Legislative Analysis and Public Policy Association (LAPPA) ### 1402686###Presenter###Senior Legislative Attorney###Legislative Analysis and Public Policy Association (LAPPA)###
Presenter: Jon Woodruff, JD (he/him/his) – Legislative Analysis and Public Policy Association (LAPPA)
### he/him/his @@@ Robert J. Valuck, PhD, RPh, FNAP (he/him/his) – University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences ### 894644###Moderator###Director, Colorado Consortium for Prescription Drug Abuse Prevention###University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences###
Moderator: Robert J. Valuck, PhD, RPh, FNAP (he/him/his) – University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
### he/him/his
NYC RxStat: Stakeholder Reflections on the First Decade of a National Model Public Health and Public Safety Partnership to Reduce Overdose Deaths

Bennett Allen, PhD, MPA – Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine ### 1827314###Presenter###Assistant Professor###Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine###
Presenter: Bennett Allen, PhD, MPA – Center for Opioid Epidemiology and Policy, NYU Grossman School of Medicine
### @@@ Adelya A. Urmanche, PhD (she/her/hers) – Mount Sinai Beth Israel ### 1827315###Presenter###Postdoctoral Research Fellow###Mount Sinai Beth Israel###
Presenter: Adelya A. Urmanche, PhD (she/her/hers) – Mount Sinai Beth Israel
### she/her/hers @@@ Rita K. Noonan, PhD – Centers for Disease Control and Prevention ### 652109###Moderator###Branch Chief, Division of Overdose Prevention###Centers for Disease Control and Prevention###
Moderator: Rita K. Noonan, PhD – Centers for Disease Control and Prevention
###